Hacker News Reader

I wonder how you deal with security concerns. I think since the result of clinical trials can have such a large impact on a pharma co's share price, there have been a number of cases where insiders with access to trial results have given information to financial trading firms who then proceed to exploit the information in the market.

how do you assure your customers that the information put in your system won't leak?

View on HN

We actually spend a lot of time thinking and dealing with security concerns, both from a software development perspective and from a devops perspective. You're correct that the data is very valuable, so a large percentage of our architecture and design decisions are dictated by security and privacy concerns.

This actually becomes even more complicated when you think about maintaining blinding, aggregate-only blinding, and some of the other features we need to support.

Reply on news.ycombinator.com